Amanda Holdan-Sinisi Joins Ripple Science as Director of Marketing
New Marketing Leadership Adds to Ripple Science’s Dynamic Momentum
Amanda Holdan-Sinisi, Ripple Science Director of Marketing
ANN ARBOR, MICHIGAN – August 20, 2019 – Ripple Science is pleased to announce Amanda Holdan-Sinisi has joined the team as the company’s Director of Marketing. Amanda comes to Ripple Science with deep experience in Silicon Valley and Germany, leading technology companies in marketing and product management.
Amanda joins Ripple most recently from BioVigil, an Ann Arbor based healthcare technology company, where she built the company’s marketing foundation, elevating BioVigil to market leader in its category.
In her new role at Ripple Science, Holdan-Sinisi will report to the CEO with the responsibility to develop and deliver a fully integrated marketing vision and strategy, including all marketing and lead generation activities for Ripple. Amanda holds a Master of Arts in Communication from the University of Louisiana, Monroe, and a Bachelor of Science from Appalachian State University.
Amanda is thrilled to help grow Ripple: “I am passionate about products and technologies that help make people’s lives better and that is exactly the value Ripple provides to customers. Giving researchers a streamlined way to manage participants is key in any clinical trial. With Ripple, customers are better prepared to deliver on-time results, and in turn, everyone benefits.”
“With Ripple’s bookings tripling in July, it’s the perfect time to bring on an executive with Amanda’s capabilities to align and further build upon our B2B strategy,” said Peter Falzon, CEO of Ripple Science. “Amanda brings a wealth of marketing and leadership experience to us.”
About Ripple Science
Ripple Science accelerates clinical research with its secure, HIPAA-compliant suite of tools. By adapting sales and marketing automation to the process of patient recruitment, Ripple helps our customers recruit more participants, faster and reduces patients lost to follow-up.
Ripple Science’s flagship product, Ripple, is currently being used by research investigators at more than 100 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.